Shimizu, Yoko <br/><br/>
Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.  [electronic resource] 

 -  Modern rheumatology  May 2018 
 - 461-467 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1439-7609 
<br/><br/><label>Standard No.: </label>10.1080/14397595.2017.1369926  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Biological Products--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged